US EditionLokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Summary by Drug Discovery and Development
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
In an industry where each lost day can drain roughly $40,000 in direct clinical-trial costs, Lokavant says its newly launched Spectrum v15 can crunch data from 500,000 past studies and deliver enrollment forecasts in five minutes, work that typically takes study teams five weeks. The company claims that the platform boasts 80+% confidence. The company,… The post Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minu…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
